Additional drugs are forth coming, including some that have long been touted by other firms, only they have not filed any "ANDA papers" regarding them, and Andrx will beat them to the market.
Sorry to learn of your misfortune's regarding some of the previous stock purchases. Im glad to see you have done at least some of your homework to know a little regarding Andrx. You bring up some points that I can address, yes Andrx realizes that the drug distribution part of their business is not the highest priority, although it is nice to have. Yes it is low margin, but combined with their drugs produced, it creates better profit margins. Andrx has established excellent contacts in Europe and the east, and I would assume that these agreements or deals will be announced in 97, with the possibilty of producing for third parties. Many other mutual funds have expressed interest in purchasing shares, but afraid of driving up prices to quickly. You will see occasional blocks of 50-70,000 shares cross the tape and just exchange hands or with a small uptick. What I have been told is that $80 is very realstic, and twice that is possible. But you will not find Andrx in the hype mill (unlike many of the companies you mentioned). They do what the say, they will almost always exceed what is expected, and announce JV's etc. only when they feel it is in the companies best interest. As not to alert competition of progress. I urge, you to follow the stock, and as soon as you see the stock rising
quickly jump in, and enjoy a profitable ride for a change. Good luck getting shares then! The whole sector has made a turn-around, although a few high flyer's will be on their way down. The sector is better poised now than the last few years, so just be cautious, many analyst's are, including David Sak's who has given conservative estimates re: Andrx. |
